Ergun Velidedeoğlu

2.2k total citations
39 papers, 1.7k citations indexed

About

Ergun Velidedeoğlu is a scholar working on Surgery, Transplantation and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Ergun Velidedeoğlu has authored 39 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Surgery, 13 papers in Transplantation and 10 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Ergun Velidedeoğlu's work include Organ Transplantation Techniques and Outcomes (17 papers), Renal Transplantation Outcomes and Treatments (13 papers) and Organ Donation and Transplantation (9 papers). Ergun Velidedeoğlu is often cited by papers focused on Organ Transplantation Techniques and Outcomes (17 papers), Renal Transplantation Outcomes and Treatments (13 papers) and Organ Donation and Transplantation (9 papers). Ergun Velidedeoğlu collaborates with scholars based in United States, Türkiye and Canada. Ergun Velidedeoğlu's co-authors include James F. Markmann, Niraj M. Desai, Adam M. Frank, Ali Naji, Clyde F. Barker, Kevin C. Mange, Joseph W. Markmann, Shaoping Deng, Xiaolun Huang and Peter L. Abt and has published in prestigious journals such as Nature Medicine, The Journal of Immunology and Diabetes.

In The Last Decade

Ergun Velidedeoğlu

38 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ergun Velidedeoğlu United States 18 1.3k 514 421 369 353 39 1.7k
Mario Vilatobá Mexico 17 642 0.5× 339 0.7× 122 0.3× 109 0.3× 142 0.4× 59 1.1k
Oliver Drognitz Germany 19 639 0.5× 386 0.8× 226 0.5× 45 0.1× 143 0.4× 54 1.3k
Willem J. Van der Werf United States 18 1.0k 0.8× 470 0.9× 510 1.2× 27 0.1× 145 0.4× 29 1.5k
Jennifer L. Larsen United States 16 345 0.3× 230 0.4× 70 0.2× 367 1.0× 109 0.3× 40 843
Lionel Badet France 17 617 0.5× 186 0.4× 177 0.4× 85 0.2× 92 0.3× 47 839
Brian Susskind United States 15 699 0.6× 902 1.8× 269 0.6× 23 0.1× 74 0.2× 36 1.3k
Ari Cohen United States 21 898 0.7× 488 0.9× 844 2.0× 18 0.0× 26 0.1× 97 1.6k
S Todo United States 16 605 0.5× 380 0.7× 125 0.3× 27 0.1× 62 0.2× 55 1.0k
Klaus‐Peter Platz Germany 14 735 0.6× 434 0.8× 521 1.2× 22 0.1× 25 0.1× 16 1.1k
Atsushi Sugitani Japan 19 686 0.5× 251 0.5× 71 0.2× 28 0.1× 63 0.2× 69 1.0k

Countries citing papers authored by Ergun Velidedeoğlu

Since Specialization
Citations

This map shows the geographic impact of Ergun Velidedeoğlu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ergun Velidedeoğlu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ergun Velidedeoğlu more than expected).

Fields of papers citing papers by Ergun Velidedeoğlu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ergun Velidedeoğlu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ergun Velidedeoğlu. The network helps show where Ergun Velidedeoğlu may publish in the future.

Co-authorship network of co-authors of Ergun Velidedeoğlu

This figure shows the co-authorship network connecting the top 25 collaborators of Ergun Velidedeoğlu. A scholar is included among the top collaborators of Ergun Velidedeoğlu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ergun Velidedeoğlu. Ergun Velidedeoğlu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chaudhri, Nadia, et al.. (2024). Approval of Mycophenolate Mofetil for Prophylaxis of Organ Rejection in Pediatric Recipients of Heart or Liver Transplants: A Regulatory Perspective. Clinical Pharmacology & Therapeutics. 116(3). 807–813. 2 indexed citations
2.
Cavaillé‐Coll, M, S Bala, Ergun Velidedeoğlu, et al.. (2013). Summary of FDA Workshop on Ischemia Reperfusion Injury in Kidney Transplantation. American Journal of Transplantation. 13(5). 1134–1148. 111 indexed citations
3.
Fox-Talbot, Karen, et al.. (2013). Absence of FcγRIII Results in Increased Proinflammatory Response in FcγRIII-KO Cardiac Recipients. Transplantation. 96(7). 601–608. 11 indexed citations
4.
Archdeacon, Patrick, Marieta Chan, Carolyn Y. Neuland, et al.. (2011). Summary of FDA Antibody-Mediated Rejection Workshop. American Journal of Transplantation. 11(5). 896–906. 139 indexed citations
5.
Liu, Chengyang, Hooman Noorchashm, Eline T. Luning Prak, et al.. (2007). B lymphocyte–directed immunotherapy promotes long-term islet allograft survival in nonhuman primates. Nature Medicine. 13(11). 1295–1298. 126 indexed citations
6.
Deng, Shaoping, Daniel J. Moore, Xiaolun Huang, et al.. (2006). Antibody-Induced Transplantation Tolerance That Is Dependent on Thymus-Derived Regulatory T Cells. The Journal of Immunology. 176(5). 2799–2807. 28 indexed citations
7.
Frank, Adam M., Shaoping Deng, Xiaolun Huang, et al.. (2004). Transplantation for Type I Diabetes. Annals of Surgery. 240(4). 631–643. 67 indexed citations
8.
Velidedeoğlu, Ergun, Roy D. Bloom, Michael D. Crawford, et al.. (2004). Early kidney dysfunction post liver transplantation predicts late chronic kidney disease. Transplantation. 77(4). 553–556. 62 indexed citations
9.
Velidedeoğlu, Ergun, Kevin C. Mange, Adam M. Frank, et al.. (2004). FACTORS DIFFERENTIALLY CORRELATED WITH THE OUTCOME OF LIVER TRANSPLANTATION IN HCV+ AND HCV- RECIPIENTS. Transplantation. 77(12). 1834–1842. 76 indexed citations
10.
Markmann, James F., Shaoping Deng, Niraj M. Desai, et al.. (2003). The use of non-heart-beating donors for isolated pancreatic islet transplantation. Transplantation. 75(9). 1423–1429. 86 indexed citations
11.
Lee, Major K., Xiaolun Huang, Daniel J. Moore, et al.. (2003). Vulnerability of allografts to rejection by MHC class II-restricted T-cell receptor transgenic mice1. Transplantation. 75(8). 1415–1422. 11 indexed citations
12.
Velidedeoğlu, Ergun, Daniel J. Moore, Xiaoyi Huang, et al.. (2002). Transgenic T cells persist in an adoptive transfer model of mouse liver transplantation tolerance. Transplantation Proceedings. 34(8). 3342–3344. 1 indexed citations
13.
Velidedeoğlu, Ergun, Michael D. Crawford, Niraj M. Desai, et al.. (2002). Predictors of late kidney dysfunction post-liver transplantation. Transplantation Proceedings. 34(8). 3315–3316. 17 indexed citations
14.
Velidedeoğlu, Ergun, Niraj M. Desai, Kim M. Olthoff, et al.. (2002). The outcome of liver grafts procured from hepatitis C-positive donors. Transplantation. 73(4). 582–587. 58 indexed citations
15.
Velidedeoğlu, Ergun, Noel N. Williams, Kenneth L. Brayman, et al.. (2002). Comparison of open, laparoscopic, and hand-assisted approaches to live-donor nephrectomy. Transplantation. 74(2). 169–172. 99 indexed citations
16.
Velidedeoğlu, Ergun, Niraj M. Desai, Luís Campos, et al.. (2001). Effect of donor hepatitis c on liver graft survival. Transplantation Proceedings. 33(7-8). 3795–3796. 3 indexed citations
17.
Velidedeoğlu, Ergun, Kenneth L. Brayman, Luís Campos, et al.. (2001). Surgical options for live-donor nephrectomy. Transplantation Proceedings. 33(7-8). 3789–3790. 4 indexed citations
18.
Haberal, Mehmet, et al.. (1995). The effect of DST in kidney transplantation between spouses.. PubMed. 27(5). 2576–2576. 5 indexed citations
19.
Velidedeoğlu, Ergun, N Bi̇lgi̇n, & Mehmet Haberal. (1993). Is it worth it to use kidneys between spouses?. PubMed. 25(3). 2185–6. 1 indexed citations
20.
Velidedeoğlu, Ergun, et al.. (1992). Factors affecting postoperative mortality in abdominal trauma.. PubMed. 77(3). 198–202. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mario Vilatobá Breakdown of academic impact, for papers by Oliver Drognitz Breakdown of academic impact, for papers by Willem J. Van der Werf Breakdown of academic impact, for papers by Jennifer L. Larsen Breakdown of academic impact, for papers by Lionel Badet Breakdown of academic impact, for papers by Brian Susskind Breakdown of academic impact, for papers by Ari Cohen Breakdown of academic impact, for papers by S Todo Breakdown of academic impact, for papers by Klaus‐Peter Platz Breakdown of academic impact, for papers by Atsushi Sugitani
Rankless by CCL
2026